National Centre for Pharmacoeconomics

National Centre for
Pharmacoeconomics

NCPE Ireland

Inhaled loxapine is indicated for the rapid control of mild-to-moderate agitation in adult patients with schizophrenia or bipolar disorder.

Rapid Review

Commenced Completed Outcome
21/06/2016 28/07/2016 Full Pharmacoeconomic Evaluation Recommended

 Not considered cost-effective due to non-submission of full pharmacoeonomic evaluation